Today in Medicine

Plamere Plasma Pen Training and Certification Program USA

Eyebrow and Eyelid Lift by Plasma Pen Pro (PPP)

Plamere Plasma Fibroblast Eyelid Lift Treatment by Plasma Pen Pro (PPP)

Plasma skin tightening is in huge demand but the number of certified technicians is low. PPP offer the best in Plasma Fibroblast Training and Certification.

MIAMI, FLORIDA, USA, November 15, 2018 /EINPresswire.com/ — The art and science of Plasma Fibroblast in the beauty industry is not a new, but with new and better technology and equipment, this treatment has now come to the forefront of the beauty industry.

Most men and women seek out the next best non-invasive, non-surgical treatment that will have them looking younger and having a more refreshed looked, without the use of chemicals, toxins or scalpels. Well, that treatment has arrived in a procedure simply called: Plasma Fibroblast. This treatment uses a Plasma Pen that produces an arc, similar to a lightning bolt, that carbonizes the skin (a controlled burn) that produces what looks like a dot on the skin. Once the skin is carbonized, it contracts, causing skin tightening, and the residual heat from the arc goes into the dermis causing the skin to produce collagen, which in turn plumps the skin. Therefore, this treatment reduces fine lines and wrinkles, and can remove moles, skin tags and even warts.

The results of having a Plasma Fibroblast treatment have been outstanding. The recovery time for such a treatment is 5-7 days, and it is only social downtime, as the carbonized dots on the skin heal. This procedure can give the client an eyelid lift, eyebrow lift, neck lift, tummy tuck, ear lift, crows feet reduction, jowl reduction, wrinkle reduction, and more. The sky is the limit with this procedure.

You've heard the good news, and now for some bad news. The quality of Plasma Pens very as much as that of lasers. The best Plasma Pen that has been sold and trained around the world is the Plamere Plasma Pen. This pen is FDA approved and CE approved, and is the only Plasma Pen Rose Cruz now uses to teach her Plamere Plasma Pen Pro Courses. "Although there are other pens on the market, we have found that the Plamere is now the leader in the plasma fibroblast industry. Insurance companies know the pen, and have been keen to insure our student in the USA knowing that we train with this pen." There are many other pens sold on asian websites, however, most of these pens are unstable and break down easily, or each pen has a different energy and can cause burns and/or scarring.

Technicians in the beauty industry can trust that Plasma Pen Pro (PPP) have the experience in the industry, and are wanting to share that experience with the next generation of Plasma Fibroblast Technicians. They have completed hundreds of treatments, and have trained hundreds of students nationally and internationally. PPP have just announced their USA Plamere Plasma Pen Pro Tour. Their tour starts in New York City on January 14-15, and Rose Cruz will be travelling from the East Coast to the West Coast to spread her knowledge in the Plasma Fibroblast Industry with all those students who want to add this treatment to their current menu offerings.

Finding new opportunities in the beauty world can often be quite difficult considering the competitive nature surrounding it that exists in most countries. That's what makes the news about plasma lifts, also known as Plasma Fibroblast treatments, so interesting from a business perspective. The even better news is the worldwide leaders in the space Rose Cruz and Plasma Pen Pro (PPP) are working on expanding their teaching reach even further – and this means bringing on new partners willing to host and distribute the Plasma Pen Pro Plasma Fibroblast Training and Certification Course. The opportunity is a win-win for all involved PPP, their partners, the students of the course, and ultimately the people who benefits from the plasma pen treatments.

“Plasma Fibroblast training is the present and future of in the beauty industry, and it is only growing bigger by the day,” remarked Rose Cruz from Plasma Pen Pro. “We have seen very real success stories from our partners and we know this is a trend that will just continue to grow. When you have a business model that works, an amazing product in plasma fibroblast training and certification, and a team that are experts in instruction, the sky is really the limit.”

Plasma Pen Pro have held successful classes across the world, in places like Canada, United States, and Australia. The team is more-than-open to discuss offering their classes and certification in a long list of other nations and encourage interested parties to reach out and discuss details.

Some of the areas plasma skin lift treatments can help include Fine Lines, Eyebrow Ptosis, Crows Feet Lines, Nasal Labial Folds, Laugh Lines, Smoker's and Kissing Lines, Neck Lines, and Drooping Skin & Loose Skin.

Reviews of the plasma fibroblast treatments continue to be positive across the board.

Janice S., from Australia, recently said, “I took Plasma Pen Pro training and achieved my certification with Rose Cruz. I was able to find a job in almost immediately and not only love it, but it pays very well. Five-stars.” More positive reviews and stories can be found on their Google page, and boasts over 30 positive reviews by students and clients alike.

For more information about Plamere Plasma Pen Procedures, or to sign up for our PPP course, be sure to visit https://www.plasmapenpro.com.

To view more pictures and videos of actual clients before and afters, please visit: http://www.instagram.com/plasmapenpro

To purchase your own Plamere Plasma Pen, please visit http://www.plamereplasmapenpro.com

Rose Cruz
Plasma Pen Pro
18444002018
email us here
Visit us on social media:
Facebook

Eyelid Lift Using Plamere Plasma Pen Pro Technique

Source: EIN Presswire

SALT LAKE CITY, UTAH, USA, November 15, 2018 /EINPresswire.com/ — Intermountain Healthcare has reached a “Masters” designation in the annual Gartner Healthcare Supply Chain Top 25 list. The Healthcare Supply Chain Top 25 ranking and designation, recognizes manufacturers, providers, distributors and retailers from across healthcare that demonstrate leadership in improving human life at sustainable costs. After being ranked in the top five over the past seven years, Intermountain is recognized in Gartner’s new Master classification, an additional dimension of achievement. Gartner is a national business consulting company who has issued the ranking the past ten years.

Intermountain earned the Master level based on sustained supply chain performance over a period of time. Intermountain was ranked #1 on the Gartner list in 2016 and 2017 and #3 the two prior years. Intermountain’s strong bond rating, its supply chain organization’s initiatives to improve value and lower healthcare costs, the health system’s comprehensive approach to serve the patient, and innovative problem solving are among the factors to achieve the newly created title.

“Our supply chain team does an outstanding job to ensure we’re using the highest quality products and services at the lowest possible cost,” said Marc Harrison, MD, president and CEO of Intermountain Healthcare. “This team continually raises the bar in quality and affordability and demonstrates—year upon year—their commitment to making a difference for those we serve. We are honored to be on this prestigious list as a Master.”

John Wright, vice president of Supply Chain and Support Services for Intermountain, adds, “This is a humbling experience to now be ranked as a Master and a designation which I’m very appreciative. Intermountain Supply Chain leaders before me staged us for this honor long ago and I'm proud to have led us the past year to continue our work forward. Recognition of this type validates our passion and conviction within the supply chain to make a difference for our patients. I know that when we move initiatives forward, we do so with the dedication and commitment to improve value.”

Learn more about the rankings and Intermountain’s Master achievement at https://www.gartner.com/doc/3893074?ref=mrktg-srch

Intermountain Healthcare is a Utah-based not-for-profit system of 23 hospitals, 170 clinics, a Medical Group with about 2,300 employed physicians and advanced practice clinicians, a health plans group called SelectHealth, and other medical services. Intermountain is widely recognized as a leader in transforming healthcare through high quality and sustainable costs. For more information about Intermountain, visit www.intermountainhealthcare.org.

Daron Cowley
Intermountain Healthcare
801-442-2834
email us here

Source: EIN Presswire

Former U.S. Drug Enforcement Administration Senior Executive joins GenCanna in an advisory capacity on a range of security and policy issues.

WINCHESTER, KENTUCKY, UNITED STATES, November 15, 2018 /EINPresswire.com/ — GenCanna Global Inc. (“GenCanna”) announced today that retired U.S. Drug Enforcement Administration Senior Executive, Special Agent in Charge, Karl Colder will be joining the company in an advisory capacity on a range of security and policy issues.

Mr. Colder’s 32-year career includes serving in the U.S. Drug Enforcement Administration as Senior Executive, Special Agent in Charge of the Washington Division Office responsible for operations in Maryland, Virginia, West Virginia and the District of Columbia, and as Deputy Chief Inspector of the DEA Office of Professional Responsibility. Before retiring in 2018, Mr. Colder led DEA efforts to fight the heroin and prescription drug abuse epidemics in West Virginia.

“I am thrilled to join the GenCanna team. Companies operating in this space on a global scale should have security, compliance, and safety as their top priorities. GenCanna knows this and they are leading by example,” said Karl Colder. He added, “Also, as the 2018 Farm Bill moves through Congress, I am pleased about the clarifications surrounding the hemp crop's removal from the Controlled Substances Act, which will benefit our nation's farmers. A partnership like ours is long overdue and I am excited about what we will accomplish together.”

GenCanna, a vertically-integrated agriculture technology company specializing in the production of industrial hemp rich in CBD has been at the forefront of developing the rapidly expanding hemp industry. The company’s relationships with law enforcement on the state and federal level has been critical to the company’s success since its founding. These relationships are crucial in distinguishing federally-compliant hemp companies from companies in the medical marijuana and recreational marijuana markets.

“Partnerships with law enforcement experts are critical to safely and securely expanding our business globally,” said Matty Mangone-Miranda, CEO of GenCanna. Mr. Mangone-Miranda continued, “We welcome retired leaders from the DEA to ATF to Interpol. Their experience is essential in creating an organization with next-level leadership.”

GenCanna's hemp-derived products are already exempted from the Controlled Substances Act through compliant participation in the state and federal structures enabled by the Agricultural Act of 2014. GenCanna’s focused regulatory efforts have been critical to the success of the company and industry. These efforts are led by Steve Bevan, a co-Founder and the Company’s current President. Mr. Bevan is a co-founder of the U.S. Hemp Roundtable and presently serves its Secretary.

“Without our work with law enforcement and policymakers the hemp industry would not be where it is today,” commented Steve Bevan, GenCanna’s President. “We want everyone in our industry to adopt a similar attitude. It is my hope that our partnership with Mr. Colder can be a template for how companies create deeper, more integrated and meaningful relationships with law enforcement and other officials.”

# # #

About GenCanna Global, Inc.

GenCanna is a vertically-integrated agriculture-technology company specializing in the production of hemp rich in CBD. Founded in 2014, as an inaugural member of the Kentucky Department of Agriculture’s Industrial Hemp Pilot Program, the company is a longstanding industry pioneer. GenCanna works closely with state universities, consumer protection agencies and other regulatory bodies driving key industry language and legislation. Consistent extraction methods and innovative processing technologies ensure GenCanna production processes exceed all regulatory standards for FDA registered and inspected food production facilities (learn more at https://gencanna.com/compliance/). The GenCanna Production Platform™ assures standardized, repeatable quality from farm to finished product.

CONTACTS:
Media
Alex Green, GenCanna
media@gencanna.com

KATHRYN BREIWA ROBERTSON
GenCanna Global Inc.™
+1 (859) 737-3770
email us here

Source: EIN Presswire

Patrick Brown makes comeback in Brampton

TORONTO, ON, CANADA, November 15, 2018 /EINPresswire.com/ — Support for Lisa MacLeod on mental health

November 15, 2018

Patrick Brown writes in the book that he went out of his way to support Lisa MacLeod when she came forward with her mental health battle. He went against the advice of the PC Chair of the Easter Ontario region and party officials and disqualified MacLeod’s nomination challengers. He articulates in his book about the support and help he provided. We know she has not read the book and we would hope that the journalistic community will review the content and report on this aspect accurately and without bias.

As Ontarian’s may be aware Mr. Brown introduced the largest proposed public investment in combating mental health in the People’s Guarantee, something the current Government continues to support.

Dean Baxendale

From Page 105-106 of the book

There was a candidate, Goldie Ghamari, who was running against MacLeod in Ottawa for the nomination. So what did I do? I called Ghamari and told her that she could run in any other riding, but not against MacLeod. Period. I thought she’d beat MacLeod handily, so I intervened to protect her. Six months later, another candidate, Ottawa businessman Riven Zhang, decided to run for the nomination against MacLeod. He had a very big Chinese community behind him. Again, I went to MacLeod and told her not to worry about the nomination because I was protecting her.

dean Baxendale
www.optimumpublishinginternational.com
+1 647-970-1973
email us here

Source: EIN Presswire

Literacy: A Vital Necessity in Today’s World event panelists, Mr. Ken Morris, Ms. Barbie Rivera, Mr. Frank Smith, Mr. John Stanard

Mr. Ken Morris, signing Frederick Douglass’ autobiography, Narrative of the Life of Frederick Douglass, an American Slave

Ms. Barbie Rivera, founder & director H.E.L.P. Miami school sharing her successes with L. Ron Hubbard’s study technology

An event on the necessity of literacy was held with the occasion of Frederick Douglass Bicentennial year at the Church of Scientology National Affairs Office

WASHINGTON, DISTRICT OF COLUMBIA, UNITED STATES, November 15, 2018 /EINPresswire.com/ — In honor of the Bicentennial Celebration of the life of Frederick Douglass, the Church of Scientology National Affairs Office hosted a panel of national and local leaders bringing to light the vital importance of literacy in the present day and providing solutions to achieving the goal of a literate nation. Frederick Douglass, a man who changed his nation and became a global icon, was born a slave but broke through the bonds of captivity because he realized that literacy would make him unfit to be a slave. This datum and the further pursuit of literacy led him to become one of the most well known American abolitionists, respected statesman, and renowned writer and orator.

Keynote speaker, Mr. Ken Morris, Jr., great-great-great grandson of Frederick Douglass and Chairman of the Congressional Frederick Douglass Bicentennial Commission, shared stories from Douglass’ autobiography, Narrative of the Life of Frederick Douglass, an American Slave written in 1845. Douglass’ master Mr. Aud, upon learning that Mrs. Aud was teaching the young Douglass to spell, said, “Now, if you teach him how to read, there would be no keeping him. It would forever unfit him to be a slave. He would at once become unmanageable, and of no value to his master.” These words sank deep into Douglass and laid the pathway to his freedom. This same idea has been found to be just as relevant today in preventing children and adults from falling prey to the modern slave trade. It has been found that educated individuals are far less likely to be trafficked. Mr. Morris founded the Frederick Douglass Family Initiatives, inspired by his progenitor, to continue the abolitionist legacy of his family and educate youth throughout the country to proof them against modern day slavery.

A study conducted by the Department of Education and the National Institute of Literacy found that, as of 2013, 32 million Americans cannot read. Millions more are considered functionally illiterate. In the 2015 to 2016 school year 6.7 million students received special education services due to having been labeled with learning disabilities and many of them have been prescribed dangerous psychotropic medications as a solution.

The second panelist, Dr. Frank Smith, Founder and Director of the African American Civil War Memorial and Museum spoke about the role and importance of museums in education today. Access to museums has been found to correlate with increased academic achievement. Noticing that access was not uniform and many children never had the opportunity, Dr. Smith has been striving to bring this access to all sectors of Washington, DC.

Panelist Ms. Barbie Rivera, educator and advocate and Founder and Director of the H.E.L.P. Miami school and tutoring center addressed illiteracy directly sharing the highly effective study methodology developed by humanitarian L. Ron Hubbard and her successes in its implementation with her students and their parents. She detailed how, with this study methodology, she has been able to take the students who come to her because they have been turned away by other schools, labeled as failures and told they were unable to learn and help them thrive, regain confidence in their abilities and graduate them into successful men and women who can make full contributions to society.

The event moderator, John Stanard, National Director of Social Betterment Programs and Policy for the Church of Scientology’s National Affairs Office, shared that "The most dangerous and destructive of all illiteracies is hidden illiteracy. This hidden illiteracy shows up in many ways in society as ‘low production’ or ‘inadequate quality of work’ or even ‘discipline of children in schools’. These symptoms may in fact be based in simple illiteracy problems which are easily addressed. With more than one billion of the world's population functionally illiterate, an effective educational methodology is not a choice, it is an obligation.”

At the end of the evening Mr. Morris signed copies of his great-great-great grandfather’s book, Narrative of the Life of Frederick Douglass, an American Slave for attendees. The donations will go towards placing copies of the book in schools to continue to uplift and inspire today’s youth to become tomorrow’s leaders.

The Church of Scientology National Affairs Office was established to address and promote collaboration on solutions and forward public policy that benefits social issues through Church-supported secular humanitarian and social betterment programs that address literacy, drug education and rehabilitation, criminal rehabilitation, human rights education and morality.

To learn more about Scientology and its programs visit www.scientology.tv. and www.scientology.org.

Thalia Ghiglia
National Affairs Office
+1 202 667 6404
email us here

Source: EIN Presswire

Baby Scan app available for IOS & Android

Baby-Scan your personal window into the womb

Baby-Scan, ultrasound made accessable

Baby-Scan,an instrument with which prospective parents can follow the development of their expected one any time, anywhere with whomever you want.

VELDHOVEN, THE NETHERLANDS, November 15, 2018 /EINPresswire.com/ — Baby-Scan is the world's first wireless 2D/3D echo scanner for home use. An instrument with which prospective parents can follow the development of their expected one any time, anywhere with whomever you want.

Baby-Scan is based in Veldhoven, the beating heart of Brainport in The Netherlands. A blend of a renowned high-tech and design hub, a versatile pool of tech-savvy entrepreneurs, and a bustling hotspot of startup success stories.

Launch at CES Las Vegas 2019

Experience pregnancy even more intensely with Baby-Scan! The world's first wireless 2D/3D echo scanner for mobile devices will soon be a fact! Empowering parents with 2D & 3D images of their developing infant, Baby-Scan and the corresponding app is slated to launch in January in Las Vegas during CES 2019, the world's gathering place for all those who thrive on the business of consumer technologies.

The application

The Baby-Scan app is an application with all kinds of fun possibilities. It allowes expecting families to get a first glimpse of their unborn baby on their phone, record and share it on a specially designed time-line. By connecting the Baby-Scanner via Wi-Fi to the Baby-Scan app, you can enjoy 2D/3D ultrasounds on any mobile device. Furthermore, the app includes a contraction timer, baby name tool and a blog with all kinds of fun facts. The Baby-Scan app is available for free from the App Store or Google Play.

Scan and share

The Baby-Scan app enables you to save and share ultrasound imagery. You decide for yourself what you are going to do with those beautiful images and who are allowed to get a glimpse. All data is securely stored in the Baby-Cloud, so you do not have to worry about the security of your images. In your Baby-Scan account you can indicate with whom you want to share the echoes. So you can comfortably surprise family and friends with an update on the growth and development of your little one.

Carefree and safe

The scanner uses ultrasound, a technique that uses sound waves. These ultrasound waves are sent into the body from the Baby-Scanner. Once through the skin, the sound emitted by the unborn fetus is reflected back to the scanner (hence the name: echo). This ultrasound is captured and converted into an image on the mobile device. These actions are completely painless and harmless. Because humans do not have ultrasound sensors, you won’t notice a thing of these sound waves. Scientific research has clinically proven that the use of the Baby-Scanner is not harmful to the development of your unborn child. The EEA and FCC have tested and approved the Baby-Scan for quality and safety and has acquired the CE and FCC certification.

The account

Each Baby-Scan unit has a unique identifying device code that enables the service department to manage and control the whole from the Baby-Cloud. Here the registration of the user's data takes place, the used number of photos, videos and the birth date of the child is recorded.

A Baby-Scan account is valid for 10 months from the moment the account is activated. With an account you can infinitely watch your little one with the possibility to save photos or videos on your timeline.

Turning an idea into a product

Enthusiastic entrepreneur Hans Mekking who stood at the cradle of Baby-Scan, earned his stripes with several successful business ventures in the Netherlands.

“Entering the consumer electronics market with an innovative product such as Baby-Scan has been a long and very interesting road from idea to final product. Most important it proves that if you have a good story combined with a group of highly skilled professionals all your inspiration will lead to designs full of innovative ideas. Baby-Scan offers expecting parents a buzz of anticipation…Happiness as a Business Model”.

For more information visit us at: https://baby-scan.nl/

Frank Bierens
Baby-Scan
+31 40 304 1709
email us here
Visit us on social media:
Facebook
LinkedIn

Baby-Scan launches the world’s first wireless 2D/3D ultrasound scanner for mobile devices

Source: EIN Presswire

Dr. Greg Vigna

What are the ramifications of the Cuevas and Corenbaum decisions as to the evidence a jury may consider in determination of cost of future medical care?

MODESTO, CALIFORNIA, UNITED STATES, November 15, 2018 /EINPresswire.com/ — Plaintiff and Defense attorneys in personal injury cases in California are trying to understand the ramifications of the Cuevas decision and Corenbaum decision as to what evidence the jury will be allowed to consider in their determination of the cost of future medical care.

The basic tenant of damages in the tort system will not be circumvented by legal decisions into the future in that an injured plaintiff will be compensate for their losses and payment for these losses will be paid by the party responsible. The admissibility of the evidence that is allowed to assist the jury in determination the actual cost of the damages is in flux.

The Cuevas Court in a medical malpractice case allowed for evidence of discounted future medical costs based on medical rates under the Affordable Care Act to the benefit of Defendant medical providers and to the detriment of the injured Plaintiff. The Sanchez Court would preclude this testimony as the cost of services would be derived from the fee schedule under the Affordable Care Act and this evidence might be considered hearsay. The Howell Court ruled that the cost of past medical damages is not admissible evidence as it relates to future medical care as past medical bills were ‘often too inflated to be meaningful’. This is in contrast to the Corenbaum Court decision that allowed for billed amounts of previous medical care to be admissible as evidence of cost of future care.

The above decisions leave uncertainty for both Defense and Plaintiff Attorneys who desire certainty in cases that are destined for trial. Academic Physician Life Care Planning, LLC utilizes experts in Physical Medicine and Rehabilitation, Orthopedic Surgeons, Interventional Pain Physicians, and Neurosurgeons who independently from the skill, knowledge, experience, and training are qualified under the Daubert standard to testify as to ‘reasonableness of cost of previous care’ and the ‘cost of future care’ because they do so on a daily basis in their own practice and through their ownership of facilities that provide such services.

Greg Vigna, MD, JD, a Certified Life Care Planner, and owner of Academic Physician Life Care Planning, LLC, understands the conflicting legal arguments and recommends attorneys to focus on the selection of the testifying experts the above conflicting decisions will have no effect on admissibility of opinion testimony as to the cost of necessity and appropriate care to the patient’s life expectancy from a physician who provides such care as part of their private practice. Academic Physician Life Care Planning, LLC provides these opinions from physicians when necessary from multiple specialties in its life care plans for no additional cost to Defendant and Plaintiff attorneys.

Greg Vigna
Academic Physician Life Care Planning
+1 800-761-9206
email us here

Source: EIN Presswire

BOERNE, TEXAS, UNITED STATES, November 15, 2018 /EINPresswire.com/ — Do you remember how hard it was being a teenager? Ninety percent of adults will go through depression at some point in their lives, but whereas an adult may develop depression over a long period of time, adolescents tend to behave more impulsively. One experience can make them feel as though life is coming to an end and they don't have any options.

People with thoughts of suicide have become so incredibly depressed they can no longer see the goodness within them. They just want the pain to stop. That’s why it's so important for students to reach out to someone who can give them that literal lifeline to hang onto, someone skillful who understands how they feel and knows how to help.

Dr. Holly Robles is a licensed professional counselor and the founder of Live and Thrive Now. Dr. Robles has dedicated her career to making schools safer to prevent teen suicide.

“As teenagers they don’t have cognitive framework to understand that it isn’t the end of the world, which puts them at great risk,” says Dr. Robles. “That’s why we have to reach out to everybody around us. We have to let them know that the resources are there, that there is someone they can go to if they are thinking of suicide or have a friend or a family member that is thinking of suicide, so they know where to take their friend or family member for help.”

This year, Dr. Robles published the Texas Suicide Safer Schools Implementation Guide, focused on suicide prevention. Her research investigations have explored conflict resolution and the effects of cyberbullying on children and adolescents' mental health, as well as understanding secondary general educators' classroom behaviors toward disruptive students.

“I’ve known I wanted to be in this field from the time I was 15 years old,” recalls Dr. Robles. “I struggled with thoughts of suicide myself. felt like nobody in the world could possibly understand what I was going through. Until I saw a counselor. This counselor told me after one visit told me I was going to be somebody amazing, and all it took was one person to believe in me. I walked out of that office and resolved to be that person for someone else and I’ve been doing it ever since.”

While some counselors may tiptoe around these questions and feelings, Dr. Robles listens for their pain and the clues for the truth they’re afraid to tell her: that they want to die.

“When you're depressed, sometimes you think, ‘I can't believe the sun had the nerve to come up today,’” says Dr. Robles. “If we can just find that one thing to keep us going, sometimes that's the thing that's going to get us over the hump until we can get through it. For a lot of kids, it's music. Sometimes it's walking in awe of nature. We have to find whatever it is that helps us to hang on.”

CUTV News Radio will feature Dr. Holly Robles in an interview with Jim Masters on November 19th at 2pm EDT and with Doug Llewelyn on November 26th at 2pm EDT.

Listen to the show on BlogTalkRadio.

If you have a question for our guest, call (347) 996-3389.

For more information on Live and Thrive Now, visit www.liveandthrivenow.com

Lou Ceparano
CUTV News
(631) 850-3314
email us here
Visit us on social media:
Facebook

Source: EIN Presswire

tissue diagnostics market

Presence of key market players and advanced healthcare systems profit the tissue diagnostics market of North America

HYDERABAD, TELANGANA, INDIA, November 15, 2018 /EINPresswire.com/ — A tissue commonly is known, is a group or layer of cells which perform a particular function and comprise vital organic records. Tissue diagnostics involves removal of a small portion of tissue from the patient’s body, which is then processed, analyzed, and tested beneath the magnifier to notice diseases similar to cancer. Advancements within the techniques and instrumentation of medical speciality facilitate for quick and correct determination, and analysis of diseases concerning the tissues. Histopathology is a study of disease in a tissue which can be accomplished by using small biopsies, splendid needle aspiration cytology, and open biopsy or surgical procedure.

The Tissue diagnostics market was valued at USD 3.66 billion in 2018 and is anticipated to be growing at a CAGR of 6.9% to acquire USD 5.11 billion by 2023. Tissue diagnosing technique is claimed to be number one in all the gold standards set in cancer prognosis as the early detection of cancer increases the survival rate of the sufferer. It helps to identify the main reason for the growth of a tumour and also to analyze the future consequences in the patients. The advances in the biotechnology and medical science supported the tissue diagnostics to be more accurate and efficient in the treatment of various cancerous cells.

View Sample Report: https://www.marketdataforecast.com/market-reports/tissue-diagnostics-market-4245/request-sample

Drivers and Restraints:

Tissue diagnostics are executed for screening, analyzing, and monitoring the response of cancer sufferers to therapy. The scope of the tissue diagnostics market consists of major technologies like ISH, IHC, digital pathology and workflow, and unique staining and products like devices and consumables that are used to decide medical facts for the diagnosis of diseases or conditions.

The increasing prevalence of cancer cases around the world is the principal factor driving the growth of the tissue diagnostics market. Furthermore, the increasing awareness of the procedure in the developing economies, rise in the health care expenditure and disposable income of the people, technological innovations in the medical care, changing lifestyles of population, favorable government reimbursements in the developed nations, growing health awareness among different demographics of the people, increase in geriatric population and other factors are also supporting the market for tissue diagnostics.

On the contrary, the lack of awareness among some sections of the population, expenses involved in the procedure, and stringent regulatory frameworks are some of the notable factors that are hindering the growth of the market.

To know more read: https://www.marketdataforecast.com/market-reports/tissue-diagnostics-market-4245/

The full report for the global tissue diagnostics market provides all the information required for the decision making and investing opportunities based on the market size, revenue, history, current trends and future predictions. It also provides the deep sights of the global market based on the product type, application, disease, end-user and regional analysis, along with the competitive landscape.

On the basis of product type, the market is segmented into
• Instruments
• Consumables

On the basis of applications, the market is segmented into
• Hematoxylin and eosin
• Immunohistochemistry
• In Situ Hybridization

On the basis of disease, the market is segmented into
• Lung Cancer
• Pancreatic Cancer
• Breast Cancer
• Lymphoma
• Others

On the basis of end-user, the market is segmented into
• Hospitals
• Diagnostics centers
• Research organizations
• Biotechnology companies
• Contract research organizations

On the basis of region, the market is segmented into
• North America
• Asia Pacific

North America followed by Europe dominates the global tissue diagnostics market, accounting for more than half of the total market share. It is attributed to the presence of key players, sophisticated healthcare facilities, and growing research activities.

Get your customized report: https://www.marketdataforecast.com/market-reports/tissue-diagnostics-market-4245/customize-report

The full report also offers useful insights about leading companies in the global marketplace. Some of the prominent firms dominating the tissue diagnostics market around the world are

• F. Hoffmann-La Roche AG
• Sigma-Aldrich Co. LLC
• Abbott Laboratories
• Agilent Technologies
• BioGenex
• Danaher Corporation

Scope of the report:
• Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
• Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
• Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
• Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
• A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions

Related reports: Overactive Bladder Treatment Market, Blood Culture Tests Market, Nuclear Medicine Diagnostics Market

About Us:

Market Data Forecast is a firm working in market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for most of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest.

Contact info:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com

MAHANTH
Market Data Forecast
+1 888-702-9626
email us here

Source: EIN Presswire

North America accounts for the lion’s share of the Varicose Vein Treatment market

HYDERABAD, TELANGANA, INDIA, November 15, 2018 /EINPresswire.com/ — The condition of enlarged veins majorly seen in feet and legs is defined as Varicose Vein. It is caused by the physiological condition, secretion changes, genetic disorders and high vital sign. Varicose Vein is generally found in women, obese population and people above the age of 40 years. Hereditary factors and constant position for extended hours also result in this condition. Around 40% of the US population are affected by this disease and more than 30 million people in the country are having venous insufficiency.

The Global Varicose Vein Treatment Market was valued at USD 328.98 million in 2018 and is estimated to reach USD 448.62 million by 2023, growing at a CAGR of 6.4%. Some of the latest advances in varicose vein treatment technology include laser ablation systems, extreme-pulsed-mild therapy, incorporation of closure structures, radiofrequency systems, and ultrasound-guided structures.

View Sample Report: https://www.marketdataforecast.com/market-reports/global-varicose-vein-treatment-market-2617/request-sample

Various advantages like less incisions, quicker recuperation prices, better achievement quotes, much less patient trauma, low adverse aspect consequences, advanced efficacy, and less post-operative headaches provided by the gadgets in the treatment are the principal factors driving the Varicose Veins market. Shift towards less-invasive treatment procedures, accessibility of advanced varicosity treatment devices, the burden of varicosity cases, rising patient compliance & liableness, growing health care expenditure, and rise in ageing population are other factors that are fuelling the Varicose Vein treatment market.

On the flip side, the high prices associate with the treatment, shortage of skilled surgeons, fierce market competition and volatile reimbursement policies are some of the factors hindering the rapid growth of the market.

Read Full Report: https://www.marketdataforecast.com/market-reports/global-varicose-vein-treatment-market-2617/

The full report of global varicose vein treatment market offers complete information about overall market size, share, trends and future developments. It also describes the global market based on the treatment, product, and regional analysis, along with the competitive landscape.

On the basis of mode of treatment, the varicose vein treatment market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation. Endovenous ablation segment accounted for the major share of the market and is likely to continue the same in the forecast period.

Based on the type of products, the global market is segmented into ablation devices, venous closure products, and surgical products. Ablation devices dominated the market in recent years and is anticipated to retain the same in the forecast period.

Based on region, the Global Varicose Vein Treatment Market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is leading the global Varicose Vein Treatment Market. This can be attributed to variety of things such as advancement in technology that leads to advancements in infrastructure, continuous lifestyle changes, increasing awareness towards health and hygiene, increasing government funds, rising prevalence of unhealthy veins, high financial gain, and growing significance of aesthetics. In addition, favourable compensation policies, significantly among the US have significantly boosted the marketplace for in North America.

The Asia Pacific Varicose Vein Treatment Market is anticipated to grow with a double digit CAGR in the forecast period, which can be attributed to a surge in financial gain, improvement in health care infrastructure, and an increase in patient awareness regarding the advantage of seeking early treatment.

Customized Report: https://www.marketdataforecast.com/market-reports/global-varicose-vein-treatment-market-2617/customize-report

The full report also provides data related to leading companies in the world market. Some of the key players in the Varicose Vein Treatment Market include Medtronic plc (Ireland), AngioDynamics, Inc. (U.S.), biolitec AG (Austria), Syneron Medical Ltd. (Israel), Lumenis Ltd. (Israel), Dornier MedTech GmbH (Germany), Energist Group (U.K.), Eufoton s.r.l. (Italy), Vascular Solutions, Inc. (U.S.), Quanta System S.p.A. (Italy), Sciton, Inc. (U.S.), Fotona d.o.o. (Slovenia), BTG plc (U.K.), and Merz Aesthetics (U.S.).

The increasing adoption of technological innovations in the manufacturing, distribution and use of gadgets in the varicose vein treatment offers lucrative growth opportunities for these market giants to capitalize the demand.

The scope of the report:
• Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
• The segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
• Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
• Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economic, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
• A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.

Related reports: Anti-neoplastic Agents Market, Blood Brain Barrier Technologies Market, Breast Imaging Market

About Us:
Market Data Forecast is a firm working in market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for most of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest.

Contact info:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555

MAHANTH
Market Data Forecast
+1 888-702-9626
email us here

Source: EIN Presswire